181 related articles for article (PubMed ID: 10688122)
1. Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.
Hornick JL; Sharifi J; Khawli LA; Hu P; Bai WG; Alauddin MM; Mizokami MM; Epstein AL
J Nucl Med; 2000 Feb; 41(2):355-62. PubMed ID: 10688122
[TBL] [Abstract][Full Text] [Related]
2. A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors.
Hornick JL; Sharifi J; Khawli LA; Hu P; Biela BH; Mizokami MM; Yun A; Taylor CR; Epstein AL
Cancer Biother Radiopharm; 1998 Aug; 13(4):255-68. PubMed ID: 10850361
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
Slavin-Chiorini DC; Kashmiri SV; Schlom J; Calvo B; Shu LM; Schott ME; Milenic DE; Snoy P; Carrasquillo J; Anderson K
Cancer Res; 1995 Dec; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors.
Khawli LA; Biela B; Hu P; Epstein AL
Hybrid Hybridomics; 2003 Feb; 22(1):1-9. PubMed ID: 12713684
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
Sharifi J; Khawli LA; Hu P; King S; Epstein AL
Hybrid Hybridomics; 2001; 20(5-6):305-12. PubMed ID: 11839248
[TBL] [Abstract][Full Text] [Related]
6. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
[TBL] [Abstract][Full Text] [Related]
7. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
Biela BH; Khawli LA; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
[TBL] [Abstract][Full Text] [Related]
9. LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumors.
Li J; Hu P; Khawli LA; Epstein AL
J Immunother; 2003; 26(4):320-31. PubMed ID: 12843794
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin.
Khawli LA; Mizokami MM; Sharifi J; Hu P; Epstein AL
Cancer Biother Radiopharm; 2002 Aug; 17(4):359-70. PubMed ID: 12396700
[TBL] [Abstract][Full Text] [Related]
11. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
[TBL] [Abstract][Full Text] [Related]
13. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tumor localization of (111)in-labeled HuCC49DeltaC(H)2 in BALB/c mice and athymic murine colon carcinoma xenograft.
Chinn PC; Morena RA; Santoro DA; Kazules T; Kashmiri SV; Schlom J; Hanna N; Braslawsky G
Cancer Biother Radiopharm; 2006 Apr; 21(2):106-16. PubMed ID: 16706631
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
Szalai G; Williams LE; Primus FJ
Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
17. A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging.
Yamamura M; Hinoda Y; Sasaki S; Tsujisaki M; Oriuchi N; Endo K; Imai K
Jpn J Cancer Res; 1996 Apr; 87(4):405-11. PubMed ID: 8641973
[TBL] [Abstract][Full Text] [Related]
18. A CDR-grafted (humanized) domain-deleted antitumor antibody.
Slavin-Chiorini DC; Kashmiri SV; Lee HS; Milenic DE; Poole DJ; Bernon E; Schlom J; Hand PH
Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481
[TBL] [Abstract][Full Text] [Related]
19. Gallium-68 chelate imaging of human colon carcinoma xenografts pretargeted with bispecific anti-CD44V6/anti-gallium chelate antibodies.
Klivényi G; Schuhmacher J; Patzelt E; Hauser H; Matys R; Moock M; Regiert T; Maier-Borst W
J Nucl Med; 1998 Oct; 39(10):1769-76. PubMed ID: 9776285
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors.
Hornick JL; Khawli LA; Hu P; Sharifi J; Khanna C; Epstein AL
Clin Cancer Res; 1999 Jan; 5(1):51-60. PubMed ID: 9918202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
